Navigation Links
Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies

duction of cells used to build blood vessels, and decreased levels of angiopoietin-2 and VEGF, the two molecules very active in building new blood vessels.

Results were spectacular in female rabbits that were given the drugs for two days before delivering their offspring prematurely. The team showed that celecoxib cut the risk in offspring of having a moderate or severe bleed in half, from 90 percent to 45 percent. The percentage was reduced even more when ZD6474 was used as well, from 45 to 27 percent, but Nedergaard and Ballabh indicate that ZD6474 is a very powerful medication not likely to be given to pregnant women in the near future.

On the whole, the best way to thwart the problem, doctors say, is to do everything possible to allow a pregnant woman to bear a pregnancy for a full 40 weeks. So doctors put a great deal of effort into preventing preterm labor. But when premature labor can't be prevented, doctors do have a few tools at their disposal to try and prevent bleeds in the germinal matrix.

"This work is very exciting, but the work is ongoing, and we must investigate the use of celecoxib more thoroughly before considering it for widespread use to prevent this problem," said Ballabh. "We can fix many problems in the premature infant, but brain damage is one problem that cannot be fixed it must be prevented. Right now there is nothing available that has been shown to be really effective at preventing this problem."


'"/>




Page: 1 2 3

Related medicine news :

1. Common contraception
2. Common Cold Remedy May Treat SARS
3. Common Plant Triggers Asthma
4. Pain Common in People with MS
5. Common Cold Found to Fight Cancer
6. Bullying – a Common Problem Among Childre
7. Common Medication Errors in Children
8. A Common Cause Of Allergy That Goes Unnoticed
9. Genetic Breakthrough in Common Eye Problem
10. Common Cold Found to Fight Cancer Cells
11. Side Effects Of Some Common Drugs

Post Your Comments:
(Date:11/21/2009)...wswire-USNewswire/ -- Tonight, in a partisan vote,...s version of the government takeover of health car...in this bill; like the public option, employer and...r elective abortion, which is the most onerous and...ides subsidies for private plans that cover electi...
(Date:11/21/2009)...ewswire-USNewswire/ -- A regional initiative launc...r blindness) in the Americas has substantially red..., as evidenced by a 31% decrease in the number of ...six endemic countries. Results were reported toda...ty of Tropical Medicine and Hygiene (ASTMH). ,...
(Date:11/21/2009)...medical apparel company launches men,s lab coats a... San Clemente, Calif. (PRWEB) November 21, 2009 -...arel, today announced the launch of its men,s lab ...ing international trade fair for the medical indus...tes its men,s collection with three varying lab co...
(Date:11/21/2009)...up ask whether there is a secret to ,alcohol rehab... London, UK (PRWEB) November 21, 2009 --... of the adult UK population drinking enough alcoho...iver disease*, it is hardly a surprise that many a...es and residential centres for help. However, for ...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- The United States Confer...essential changes its health reform bill in order ...nd conscience protection on abortion, protect acce...g provisions for adequate affordability. ,, The...ormous disappointment" that creates new and unacce...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
... , In her PhD, defended at the University of the B...ded a clinical-forensic evaluation of brain injuri...e the length of legal time periods. , Brain injur...inical level, the increase in the efficacy of inte...
...rtnership announced today they are joining three d...undation, the Oncology Nursing Society Foundation ... Lung Cancer in continuing the mission to increase...omen in the United States but it receives less res...
...w Acquisitions in Canada and Puerto Rico, Essilor...ee new,acquisitions., The Company is stepping up ...erations in Bulgaria. Its new subsidiary Essilor B...e,acquisition will enable the Company to enhance i...
...tly,released Audit Bureau of Circulations FAS-FAX ...ease of 5.8 percent paid circulation in the,period...me period in the,previous year. This increase was ... Publisher Bill Harper chalks this up to the comm...
...ure Global Limited,unveils the VEGO Power Blocker,...lution. With VEGO Power Blocker, cellphone users c...ion., Be Protected, VEGO Power Blocker Kills the ...with unique radiation shielding alloy, capable to ...
...titute have found a previously unknown molecular p...vessels when body parts are jeopardized by poor ci...o the understanding of blood vessel formation. In ...s and cancer. The paper appears in the Feb. 21 iss...
Other Medicine News:Health News:Guidelines for evaluation of psychological side-effects of brain injury 2Health News:Guidelines for evaluation of psychological side-effects of brain injury 3Health News:National Lung Cancer partnership 2Health News:Essilor Enters Bulgarian Market 2Health News:Yoga Journal Circulation Increases 5.8 Percent in Second Half of 2007 from Same Period Previous Year 2Health News:Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named 'VEGO Power Blocker' 2Health News:Another way to grow blood vessels 2
(Date:11/19/2009)...Nov. 19 BioCryst Pharmac...e pricing of a public offering of 5,000,000 shares... in gross proceeds of $48.75 million. All of the ...n effective shelf registration statement previousl...n. BioCryst has also granted the underwriters a 3...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
(Date:11/19/2009)...., Nov. 19 Alexza Pharma...hat its corporate presentation will be webcast liv... Conference on Wednesday, December 2, 2009 at 9:00...ast from The New York Palace Hotel in New York and...dent and CEO. ,, To access the live presentat...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Volcano Corporation Praises FAME Study Results 58216 1Volcano Corporation Praises FAME Study Results 58216 2Volcano Corporation Praises FAME Study Results 58216 3Volcano Corporation Praises FAME Study Results 58216 4Volcano Corporation Praises FAME Study Results 58216 5Face Masks Fly Off Shelves in Preparation for Flu Season 5047 1Face Masks Fly Off Shelves in Preparation for Flu Season 5047 2MAQUET Cardiovascular Receives FDA Clearance for MEGA 28TM 29 the Worlds First 8Fr 50cc Intra Aortic Balloon Catheter 58213 1MAQUET Cardiovascular Receives FDA Clearance for MEGA 28TM 29 the Worlds First 8Fr 50cc Intra Aortic Balloon Catheter 58213 2MAQUET Cardiovascular Receives FDA Clearance for MEGA 28TM 29 the Worlds First 8Fr 50cc Intra Aortic Balloon Catheter 58213 3
...e, Inc. a privately,held biotechnology company, an...ticipant in a clinical trial to evaluate the safet...ics of PI-2301, a novel peptide copolymer,for the ...ne diseases. The Phase I single ascending dose, d...ll involve 56 healthy male volunteers who will rec...
...hold,Pharmaceuticals, Inc. (Nasdaq: THLD ), will ...scuss the Phase 2 and Phase 3 presentations that w...ng the Company on the conference call will be Dr. ... the Indiana University Cancer Center,in Indianapo...igator on,Threshold,s Phase 2 glufosfamide trial i...
Other Medicine Technology:Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis 2Threshold to Host Conference Call to Discuss Results From Clinical Presentations at European Cancer Conference (ECCO) 2
Ishihara 14 plate color vision testing set
Ishihara Test Unlettered Pediatric 10 Plate Book
Ishihara Test 38 Plate Book
MVR Blades
Medicine Products: